Lenacapavir: There are mounting concerns over transparency in costSouth Africa may be able to start rolling out lenacapavir (LEN), the twice-yearly HIV prevention jab, in January 2026 – three months earlier than initially planned. “There is a commitment from The Global Fund of US$29 million ringfenced for lenacapavir over the next two and a half years,” says Buthelezi. Lack of transparency“We need LEN, but we need transparency,” says Dr Thembisile Xulu. While delivering the memorandum, Treatment Action Campaign’s Gcinumzi Sawuka said to Phaahla: “Gilead, just like PEPFAR, are bullying South Africa. At the negotiated price, it was reported by Bhekisisa, around 400,000 people in South Africa will get the jab.